Glucagon-receptor-antagonism-mediated β-cell regeneration as an effective anti-diabetic therapy

Autor: Xi, Yannan, Song, Benbo, Ngan, Iris, Solloway, Mark J., Humphrey, Mark, Wang, Yan, Mondal, Kalyani, Wu, Hao, Liu, Wenhui, Lindhout, Darrin A., Li, Diana, Matern, Hugo, Kekatpure, Avantika, Haldankar, Raj, Kaplan, Daniel D., Yang, Hong, Pedersen, Ophelia, Chen, Anna, Zhou, Mei, Winans, Bethany, Guo, Wei, Kutach, Alan, Fanget, Marie, Fox, Michael, Tang, Jie, Zha, Jiping, Younis, Husam, Shen, David, DePaoli, Alex, Tian, Hui, Liu, Zhonghao

Publikováno v: In Cell Reports 31 May 2022 39(9)

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Publisher Correction: Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation.

Autor: Weng JH; Department of Systems Biology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA. jui-hsia_weng@hms.harvard.edu., Koch PD; Department of Systems Biology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA., Luan HH; NGM Biopharmaceuticals, South San Francisco, CA, USA., Tu HC; Alnylam Pharmaceuticals, Inc., Cambridge, MA, USA., Shimada K; Department of Systems Biology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA., Ngan I; NGM Biopharmaceuticals, South San Francisco, CA, USA., Ventura R; NGM Biopharmaceuticals, South San Francisco, CA, USA., Jiang R; Department of Systems Biology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA., Mitchison TJ; Department of Systems Biology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA. timothy_mitchison@hms.harvard.edu.

Publikováno v: Nature metabolism [Nat Metab] 2021 May; Vol. 3 (5), pp. 728.